𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anticancer drug activity in human bladder tumor cell lines

✍ Scribed by Harvey B. Niell; Kim C. Webster; Elizabeth E. Smith


Publisher
John Wiley and Sons
Year
1985
Tongue
English
Weight
600 KB
Volume
56
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Truncated midkine correlates with sensit
✍ Natsuyo Akuzawa; Shigenori Nobata; Takao Shinozawa πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 213 KB

## Abstract Midkine (MK) is a heparin binding growth factor having functions of neurite‐outgrowth, mitogenesis and tissue repair. This molecule is involved in tumor growth and metastasis. The MK molecule consists of five exons, but there is a truncated isoform, lacking exon 3. We established SW13 c

Tumor-suppressive activity of the growth
✍ Andreas Evdokiou; Prudence A. Cowled πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 261 KB πŸ‘ 2 views

The GAS1 gene product induces growth arrest through a p53-dependent mechanism. To investigate whether GAS1 is a tumor suppressor gene, we transfected GAS1-negative human tumor cells with GAS1 plasmids and analyzed growth characteristics of stable transfectants. When a constitutively expressing GAS1

Tumor type-specific differences in cell-
✍ James Varani; Paul E. McKeever; Vishva Dixit; Thomas E. Carey; Suzanne E. G. Flg πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 French βš– 981 KB

Cell lines derived from human tumors of 4 different histo-described (Carey et al., 1976;Kimmel and Carey, 1986; logical types (SWamous carcinoma, melanomas, gliomas and McKeever et al., 1986; Varani et al., 1986). All of the lines a fibrosarcoma) were examined for cell-substrate adhesion on were gro

Synergistic anticancer activity of curcu
✍ R. Manikandan; M. Beulaja; C. Arulvasu; S. Sellamuthu; D. Dinesh; D. Prabhu; G. πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 463 KB

## Abstract The most practical approach to reduce morbidity and mortality of cancer is to delay the process of carcinogenesis by usage of anticancer agents. This necessitates that safer compounds are to be critically examined for anticancer activity especially, those derived from natural sources. A